Becton, Dickinson and Company

(New York Stock Exchange)
Back to all articles
Bullish +75

Jim Cramer on Becton, Dickinson: “I Think You Buy Some and Then You Wait” - Yahoo Finance

AI-generated analysis

📈 Jim Cramer praised Becton, Dickinson (BDX) as a major medical supply and technology company that recently 'shot the lights out' with earnings.

💰 The stock delivered a huge beat in both revenue and profit, prompting management to raise its full-year earnings forecast.

📉 Cramer noted BDX is trading at the lowest valuation level he has ever seen for the company.

🚀 The stock rallied nearly 6% on the day of the report despite a not-so-great overall market performance.

🏥 Becton, Dickinson is benefiting from technology that enables hospitals to do more with fewer people.

⏳ Cramer advises investors to buy some shares now and wait to see if the stock oversells further before adding more.

Bullish Signals
  • BDX delivered a strong earnings beat in both revenue and profit, exceeding market expectations.
  • Management has raised its full-year earnings forecast, signaling confidence in future performance.
  • The company is successfully leveraging technology to improve hospital efficiency and reduce staffing needs.
  • Jim Cramer describes the current stock price as 'very inexpensive' and trading at a historic low valuation.
  • The stock gained nearly 6% in value on the day of the report despite broader market weakness.
Full Analysis
Becton, Dickinson and Company (NYSE:BDX) received strong praise from Jim Cramer on Yahoo Finance's 'Mad Money' following a recent earnings report. Cramer highlighted that the medical supplies and technology giant delivered a significant beat in both top-line revenue and bottom-line profit. He noted that management has raised its full-year earnings forecast, demonstrating excellent execution across the business. Cramer emphasized that BDX is trading at what he considers the lowest valuation level he has ever seen for the stock. Despite broader market concerns about near-term headwinds from increased AI-related spending, Cramer views BDX as a solid buy-and-hold opportunity. He specifically pointed out that the company benefits from technology helping hospitals operate more efficiently with fewer staff. The stock surged nearly 6% on the day of the commentary despite a generally poor market environment. While Cramer acknowledged that other AI stocks might offer greater upside potential, he maintained that BDX is very inexpensive and suggested investors buy some shares to wait for any further downside before accumulating more.